These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5716114)

  • 21. [Retreatment and clinical judgment based on the criteria of the Committee on Pulmonary Tuberculosis].
    Aoyagi T
    Saishin Igaku; 1966 Jan; 21(1):102-9. PubMed ID: 5965931
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tuberculosis in the rural areas of Zaire. Report on 15 years of activity in the antituberculosis center of Kisenge. Comparative study of various chemotherapeutic schemes. Conclusions in favor of ambulatory treatment. Problems of abandonment during treatment. Causes and prevention].
    Baudry A
    Acta Tuberc Pneumol Belg; 1972; 63(3):156-205. PubMed ID: 4539950
    [No Abstract]   [Full Text] [Related]  

  • 24. [The chemotherapy of tuberculosis].
    Mitchison DA
    Cas Lek Cesk; 1984 Feb; 123(6):145-52. PubMed ID: 6697362
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Re-treatment of refractory pulmonary tuberculosis].
    Ogata H
    Kekkaku; 1992 Oct; 67(10):674-6. PubMed ID: 1453570
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recommendations of the Problem Commission on "Lung Diseases and Tuberculosis" for the chemotherapy of tuberculosis].
    Z Arztl Fortbild (Jena); 1968 Jan; 62(2):116-22. PubMed ID: 5303806
    [No Abstract]   [Full Text] [Related]  

  • 29. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 30. [Controversial questions of current chemotherapy of tuberculosis].
    Eínis VL; Tuganova VE
    Probl Tuberk; 1966; 44(3):20-6. PubMed ID: 5995847
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 32. [Controlled clinical trial of a 3-month regimen and 2 5-month regimens in the treatment of pulmonary tuberculosis. 2d study of the short-term treatment administered in Madras].
    Tripathy SP
    Bull Int Union Tuberc; 1983 Jun; 58(2):97-101. PubMed ID: 6360263
    [No Abstract]   [Full Text] [Related]  

  • 33. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 35. [Multiple resistance in tuberculosis: treatmet with chemotherapeutic combinations changed every 2 days].
    Seri I; Papp A; Illés I; Szabó A; Lukács G
    Prax Pneumol; 1967 May; 21(5):275-83. PubMed ID: 5600335
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic results in a further group of patients found to be carriers of resistant Koch bacilli].
    Radu SC; Lucreţiu R; Sevastre I; Niculescu A
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):55-9. PubMed ID: 5552572
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H; Takahashi R; Nakai T; Torii R; Yo I
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of tuberculosis].
    Eier A; Grass S
    Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of tuberculosis today: to prescribe is not enough. A case report].
    Rogasi PG; Viganò S; Leoncini F
    Ann Ital Med Int; 1996; 11(3):211-5. PubMed ID: 8998268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.